Our study reveals the interaction between PD-L1 and VEGFR signaling pathway in GBM-educated macrophages, which may provide theoretical evidences for the combined application of immune checkpoint inhibitors (ICIs) and anti-angiogenesis therapies in the treatment of GBM. The gene discussed is KDR; the disease is glioblastoma.